Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0B5AZ
|
|||
Former ID |
DNC004603
|
|||
Drug Name |
Cytotoxin Peptide Conjugate
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Somatostatin receptor type 1 (SSTR1) | Target Info | Inhibitor | [1] |
Somatostatin receptor type 2 (SSTR2) | Target Info | Inhibitor | [1] | |
Somatostatin receptor type 3 (SSTR3) | Target Info | Inhibitor | [1] | |
Somatostatin receptor type 4 (SSTR4) | Target Info | Inhibitor | [1] | |
Somatostatin receptor type 5 (SSTR5) | Target Info | Inhibitor | [1] | |
KEGG Pathway | Neuroactive ligand-receptor interaction | |||
cAMP signaling pathway | ||||
Gastric acid secretion | ||||
Panther Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||
Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | ||||
Pathwhiz Pathway | Gastric Acid Production | |||
Reactome | Peptide ligand-binding receptors | |||
G alpha (i) signalling events | ||||
WikiPathways | GPCRs, Class A Rhodopsin-like | |||
Peptide GPCRs | ||||
GPCR ligand binding | ||||
GPCR downstream signaling | ||||
SIDS Susceptibility Pathways | ||||
GPCRs, Other |
References | Top | |||
---|---|---|---|---|
REF 1 | An adjustable release rate linking strategy for cytotoxin-peptide conjugates. Bioorg Med Chem Lett. 2003 Mar 10;13(5):799-803. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.